Julphar would be the “Lead Companion” for the World Manufacturing Portfolio supported by the Emirates Drug Institution (EDE).
The 14th AIM Congress 2025 version goals to unify international efforts, improve strategic cooperation, and spotlight the position of funding in driving innovation.
UAE is strategically establishing itself as a worldwide hub for commerce, manufacturing, and healthcare improvements.
AIM Congress has formally introduced its partnership with Gulf Pharmaceutical Industries (Julphar) because the “Lead Companion” for the World Manufacturing Portfolio supported by the Emirates Drug Institution (EDE) on the 14th Version of AIM Congress 2025 in Abu Dhabi, United Arab Emirates.
AIM Congress, supported by over 400 native, regional, and worldwide companions, serves as a premier platform for fostering collaboration and advancing financial improvement by funding.
The Congress goals to unify international efforts, improve strategic cooperation, and spotlight the pivotal position of funding in driving innovation, financial progress, and the sustainability of key industries.
The strategic partnership between AIM Congress and Julphar underscores a shared dedication to strengthening collaborative initiatives, fostering data alternate, and accelerating sustainable progress and digital transformation within the manufacturing sector.
UAE as a worldwide hub of commerce
This collaboration aligns with the UAE’s imaginative and prescient to determine itself as a worldwide hub for commerce, manufacturing, and healthcare improvements, facilitating overseas direct funding (FDI) and reinforcing the nation’s management within the pharmaceutical business.
Mr. Basel Ziyadeh, CEO of Gulf Pharmaceutical Industries (Julphar), expressed his enthusiasm for the partnership, stating: “For over 4 a long time, Julphar has been on the forefront of the pharmaceutical business, setting benchmarks for excellence and innovation whereas enjoying an important position in shaping the UAE’s pharmaceutical panorama.”
Ziyadeh added: “We’re honored to collaborate with the Emirates Drug Institution (EDE) and AIM Congress, to drive impactful developmental methods, promote teamwork, and domesticate partnerships that improve equitable entry to high-quality healthcare options. This collaboration contributes considerably to strengthening international, regional, and nationwide well being safety.”
Dawood Al-Shezawi, President of AIM World Basis and Chairman of the AIM Congress Organizing Committee, emphasised the significance of this partnership and its position in supporting AIM Congress aims. He identified that collaborating with a number one firm like Julphar enhances efforts to develop the commercial sector and helps the summit’s imaginative and prescient of constructing a sustainable funding ecosystem that contributes to international financial improvement.
AIM Congress 2025 to champion pharmaceutical manufacturing
He additionally highlighted the important position performed by the pharmaceutical manufacturing sector in supporting nationwide economies, strengthening healthcare safety, and offering modern options that enhance high quality of life. He famous that this partnership represents a strategic step in the direction of advancing the pharmaceutical business and attracting extra investments to this important sector.
As one of many core portfolios of AIM Congress 2025, World Manufacturing will deal with the theme: “From Business 4.0 to five.0: Leveraging Expertise & Advancing Good Factories.” The discussions will discover the transformation of producing ecosystems, product innovation, operational effectivity, and sustainability. Key areas of focus embrace minimizing guide processes, optimizing useful resource utilization, guaranteeing employee security, and enhancing productiveness and competitiveness. The portfolio may even tackle how superior applied sciences allow firms to navigate future challenges and unexpected disruptions in an evolving international panorama.
The World Manufacturing portfolio highlights the pharmaceutical business as a key drive in innovation, leveraging sensible manufacturing, information analytics, and automation to boost high quality, effectivity, and sustainability.
Fifth Industrial Revolution
By adopting cutting-edge applied sciences from the Fifth Industrial Revolution, pharmaceutical producers are bettering productiveness, accelerating analysis and improvement, and decreasing waste—serving to to satisfy the rising demand for reasonably priced medicines whereas guaranteeing long-term sustainability.
Past manufacturing, the business performs an important position in international well being safety. Superior applied sciences like synthetic intelligence and the Web of Issues improve high quality management and product security, whereas automation and digitalization enhance provide chain effectivity, enabling quicker responses to well being crises.
Investing on this sector is crucial for financial progress and group well-being, reinforcing its position as a pillar of innovation and resilience.
Learn additionally: AIM Congress 2025 to host boards tackling international market challenges and funding traits
